Updated results of a phase II randomized trial with high dose proton pump inhibitors and metronomic capecitabine as salvage treatment for patients with advanced gastrointestinal tumours

被引：0
|
作者：
Roberto, M. [1 ]
Arrivi, G. [2 ]
Milano, A. [1 ]
D'Antonio, C. [1 ]
Romiti, A. [3 ]
Falcone, R. [1 ]
Mazzuca, F. [1 ]
Fais, S. [4 ]
Marchetti, P. [1 ]
机构：
[1] Univ Roma La Sapienza, St Andrea Hosp, Rome, Italy
[2] St Andrea Hosp, Rome, Italy
[3] Univ Roma La Sapienza, St Andrea Hosp, Oncol Dept, Rome, Italy
[4] Ist Super Sanita, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 160
引用
收藏
页数：2
相关论文
共 50 条
  • [41] A phase II trial of docetaxel and cisplatin combination in patients with locally advanced undifferentiated carcinoma of the nasopharynx: Updated results
    Farugui, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 152 - 152
  • [42] CETUXIMAB IN COMBINATION WITH CAPECITABINE, IRINOTECAN, AND RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER: RESULTS OF A PHASE II MARGIT TRIAL
    Horisberger, Karoline
    Treschl, Anne
    Mai, Sabine
    Barreto-Miranda, Manuel
    Kienle, Peter
    Stroebel, Philipp
    Erben, Philipp
    Woernle, Christoph
    Dinter, Dietmar
    Kaehler, Georg
    Hochhaus, Andreas
    Post, Stefan
    Willeke, Frank
    Wenz, Frederik
    Hofheinz, Ralf-Dieter
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1487 - 1493
  • [43] PHASE-II STUDY OF HIGH-DOSE 4'-EPIDOXORUBICIN IN THE TREATMENT OF ADVANCED GASTROINTESTINAL CANCER
    VOROBIOF, DA
    FALKSON, G
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (03): : 563 - 564
  • [44] Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients
    Bottini, Alberto
    Generali, Daniele
    Brizzi, Maria Pia
    Fox, Stephen B.
    Bersiga, Alessandro
    Bonardi, Simone
    Allevi, Giovanni
    Aguggini, Sergio
    Bodini, Giuliana
    Milani, Manuela
    Dionisio, Rossana
    Bernardi, Claudio
    Montruccoli, Arianna
    Bruzzi, Paolo
    Harris, Adrian L.
    Dogliotti, Luigi
    Berruti, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (22) : 3623 - 3628
  • [45] High dose intravenous proton pump inhibitors (IV PPI) decrease hospital mortality in selected patients with upper gastrointestinal bleeding
    Sabbah, S
    Barkun, A
    Rahme, E
    Benhaberou-Brun, D
    Armstrong, D
    Chiba, N
    Cockeram, A
    Enns, R
    Fedorak, R
    Gregor, J
    Lahaie, R
    Love, J
    Marcon, N
    Fallone, C
    Sebaldt, R
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S230 - S230
  • [46] Metronomic chemotherapy plus/minus antiinflammatory treatment in far-advanced melanoma: A randomized multi-institutional phase II trial
    Reichle, A
    Vogt, T
    Coras, B
    Bross, K
    Terhheyden, P
    Neuber, K
    Trefzer, U
    Schultz, E
    von Weikersthal, LF
    Andreesen, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 226S - 226S
  • [47] A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas
    Ni, Lu
    Zhang, Weihan
    Chen, Ye
    Leng, Weibing
    Gou, Hongfeng
    Hu, Jiankun
    Qiu, Meng
    MEDICINE, 2021, 100 (17) : E25493
  • [48] Dose effect of ipilimumab in patients with advanced melanoma: Results from a phase II, randomized, dose-ranging study
    Hamid, O.
    Chin, K.
    Li, J.
    Neyns, B.
    Linette, G.
    Negrier, S.
    Lutzky, J.
    Hoos, A.
    Wolchock, J.
    Lebbe, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [49] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)
    Andrea Camerini
    Cheti Puccetti
    Sara Donati
    Chiara Valsuani
    Maria Cristina Petrella
    Gianna Tartarelli
    Paolo Puccinelli
    Domenico Amoroso
    BMC Cancer, 15
  • [50] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)
    Camerini, Andrea
    Puccetti, Cheti
    Donati, Sara
    Valsuani, Chiara
    Petrella, Maria Cristina
    Tartarelli, Gianna
    Puccinelli, Paolo
    Amoroso, Domenico
    BMC CANCER, 2015, 15
12345